Introduction
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), emerged in China in early December 2019. Since May 18, 2020, COVID-19 has been responsible for more than 4 million cases of infection and more than 300 000 deaths worldwide. Europe was the second cluster of the pandemic after China the Americas1.Most of the studies performed worldwide found that the children are less affected by SARS-CoV-22. However, despite less severe disease and much lower case-fatality rate, infants younger than 12 months represented almost 18% of children with COVID-19 3. This population of children seemed to be more vulnerable to COVID-19, with mild to moderate severity presentation3. In at different cohort, less than 5% of children had oxygen saturation values < 95%, and wheezing episodes were not reported2,4.
Acute bronchiolitis is characterized by fever, nasal discharge and dry, wheezy cough. Here, we report 2 cases of COVID-19 in infants < 3 months old admitted to our paediatric unit. The infants presented fever and neurological symptoms and after a short period, acute bronchiolitis.